Clinical Efficacy and Safety of T1225 Versus Tobramycin 0.3 % Eye Drops in the Treatment of Purulent Bacterial Conjunctivitis of Children.

Clinical trial NCT01155999 · COMPLETED

Trial details

NCT number: NCT01155999
Sponsor: Laboratoires Thea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Purulent Bacterial Conjunctivitis

Start date: 2008-12-01
Primary completion: 2011-02-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.